48 assets in Central Nervous System Neoplasm

Therapeutic assets addressing Central Nervous System Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Irinotecan Central Nervous System Neoplasm	EpicentRx, Inc.	P2	BBB (74)
Etoposide Central Nervous System Neoplasm	NewLink Genetics Corporation	P3	BBB (73)
Thalidomide Central Nervous System Neoplasm	Medical University of Vienna	P2	BB (70)
Cyclophosphamide Central Nervous System Neoplasm	UNICANCER	P3	BB (69)
Cytarabine Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	BB (65)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)- Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	BB (64)
Olaparib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	BB (64)
Celecoxib Central Nervous System Neoplasm	Medical University of Vienna	P2	B (62)
Avapritinib Central Nervous System Neoplasm	Blueprint Medicines Corporation	P1/2	B (60)
Cabozantinib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	B (60)
Lenalidomide Central Nervous System Neoplasm	Institut Curie	P1/2	B (60)
Capecitabine Central Nervous System Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	B (57)
PI3K/MTOR INHIBITOR LY3023414 Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	B (57)
Rvp-001 Central Nervous System Neoplasm	Reveal Pharmaceuticals Inc.	P2	B (57)
Selumetinib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	B (57)
Tazemetostat Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	B (57)
Tozuleristide Central Nervous System Neoplasm	John Yu	P2	B (57)
Vemurafenib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)
Entinostat Central Nervous System Neoplasm	University Hospital Heidelberg	P1/2	CCC (54)
Nivolumab Central Nervous System Neoplasm	National Cancer Institute (NCI)	P1/2	CCC (54)
Ensartinib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Ivosidenib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Larotrectinib Central Nervous System Neoplasm	Children's Oncology Group	P2	CCC (53)
L-Methionine Central Nervous System Neoplasm	St. Jude Children's Research Hospital	P2	CCC (53)
Palbociclib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493 Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Selpercatinib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Ulixertinib Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Abemaciclib Central Nervous System Neoplasm	Stemline Therapeutics, Inc.	P1/2	CCC (48)
Elacestrant Central Nervous System Neoplasm	Stemline Therapeutics, Inc.	P1/2	CCC (48)
Ibrutinib Central Nervous System Neoplasm	Institut Curie	P1/2	CCC (48)
LMP744 Central Nervous System Neoplasm	National Institute of Neurological Disorders and Stroke (NINDS)	P1/2	CCC (48)
Neratinib Central Nervous System Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CCC (48)
Repotrectinib Central Nervous System Neoplasm	Turning Point Therapeutics, Inc.	P1/2	CCC (48)
Trastuzumab Central Nervous System Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CCC (48)
Entrectinib Central Nervous System Neoplasm	Hoffmann-La Roche	P1/2	CC (47)
Midazolam Central Nervous System Neoplasm	Blueprint Medicines Corporation	P1	CC (47)
Infigratinib Central Nervous System Neoplasm	Helsinn Healthcare SA	P1/2	CC (44)
Avutometinib Central Nervous System Neoplasm	Memorial Sloan Kettering Cancer Center	P1	CC (43)
b7-h3-car t cells Central Nervous System Neoplasm	St. Jude Children's Research Hospital	P1	CC (43)
Edotreotide Central Nervous System Neoplasm	ITM Solucin GmbH	P1	CC (43)
G 207 Central Nervous System Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
mt027 Central Nervous System Neoplasm	Suzhou Maximum Bio-tech Co., Ltd.	P1	CC (43)
Onc 206 Central Nervous System Neoplasm	Sabine Mueller, MD, PhD	P1	CC (43)
Phst001 Central Nervous System Neoplasm	Pheast Therapeutics	P1	CC (43)
Sotigalimab Central Nervous System Neoplasm	Pediatric Brain Tumor Consortium	P1	CC (42)
Radiosensitizer Rrx-001 Central Nervous System Neoplasm	EpicentRx, Inc.	P1	CC (41)
Fenofibric Acid Central Nervous System Neoplasm	Medical University of Vienna	P2	NR ()